Written by Klarity Editorial Team
Published: May 19, 2026

Last updated: July 9, 2026
Cigna plans in Florida may cover weight loss treatment — including GLP-1 medications, behavioral obesity management, and nutrition counseling — under your medical or pharmacy benefits administered through Express Scripts (ESI). Coverage depends on your specific plan type, formulary tier, prior authorization requirements, and documentation of medical necessity. Klarity Health offers online weight loss treatment in Florida with 2,000+ licensed providers. See if your Cigna plan may cover weight loss care at Klarity.
Coverage varies by plan and is not guaranteed. Verify your specific benefits with Cigna or through Klarity’s benefits check before booking.
Cigna offers several plan types in Florida through its Evernorth health services platform. Your weight loss coverage — including GLP-1 medication access — depends on which plan type you are enrolled in:
Employer-sponsored Cigna plans may have additional plan designs. Always review your Summary of Benefits and Coverage (SBC) and your Express Scripts formulary document for your specific plan year.
Pharmacy benefits for most Cigna commercial plans in Florida are administered by Express Scripts (ESI), a subsidiary of Evernorth. The table below reflects general Express Scripts formulary positioning for GLP-1 weight loss medications. Actual coverage depends on your employer’s specific plan design and any formulary updates your plan has adopted.
| Medication | Generic Name | Formulary Tier (Typical) | Prior Authorization | Indication | Notes |
|---|---|---|---|---|---|
| Wegovy | Semaglutide 2.4 mg | Tier 3–4 | Required | Chronic weight management | PA criteria: BMI ≥ 30 or ≥ 27 with comorbidity; may require documentation of prior lifestyle program; non-diabetic indication |
| Zepbound | Tirzepatide (weight loss dose) | Tier 3–4 (verify) | Required | Chronic weight management | ESI formulary differs from CVS/Caremark; check your current plan formulary — coverage not guaranteed on all Cigna plans. PA and BMI criteria apply. |
| Saxenda | Liraglutide 3.0 mg | Tier 3–4 | Required | Chronic weight management | May serve as step therapy before Wegovy on some plans; BMI and comorbidity documentation required |
| Ozempic | Semaglutide 0.5–2.0 mg | Tier 2–3 (diabetes indication only) | Required (diabetes Dx) | Type 2 diabetes | NOT covered for weight loss as primary indication on most plans; requires documented type 2 diabetes diagnosis |
| Mounjaro | Tirzepatide (diabetes dose) | Tier 2–3 (diabetes indication only) | Required (diabetes Dx) | Type 2 diabetes | NOT covered for weight loss as primary indication on most plans; requires documented type 2 diabetes diagnosis |
| Rybelsus | Oral semaglutide 3–14 mg | Tier 3 | Required (diabetes Dx) | Type 2 diabetes | Diabetes indication only; not typically covered for weight management |
Formulary tiers and PA requirements are subject to change by Express Scripts and vary by employer plan. Always verify your current formulary at express-scripts.com or through your myCigna portal before starting treatment.
Cigna plans may also cover non-GLP-1 oral weight loss medications through Express Scripts pharmacy benefits. These are often lower-cost alternatives or adjuncts to GLP-1 therapy:
| Medication | Generic Name | Schedule | Formulary Tier | Prior Authorization | Notes |
|---|---|---|---|---|---|
| Phentermine | Phentermine HCl | Schedule IV | Tier 1–2 | Usually not required | Short-term use (typically ≤ 12 weeks); BMI ≥ 30 or ≥ 27 + comorbidity. Schedule IV — EPCS not required (see EPCS section below) |
| Qsymia | Phentermine-topiramate ER | Schedule IV + REMS | Tier 3–4 | Required | REMS program requires prescriber certification; PA and BMI documentation required; Schedule IV — not subject to FL § 456.44 EPCS mandate |
| Contrave | Naltrexone-bupropion ER | Non-scheduled | Tier 3–4 | Required | Non-controlled; PA typically requires BMI threshold and prior lifestyle program documentation |
| Orlistat (Xenical) | Orlistat 120 mg | Non-scheduled | Tier 2–3 | Usually not required | OTC version (Alli 60 mg) also available; works by reducing dietary fat absorption; not a controlled substance |
Most Cigna plans in Florida require prior authorization (PA) for GLP-1 weight loss medications through Express Scripts. General PA criteria include:
Klarity Health’s clinical team may assist with the prior authorization process. Verify specific PA criteria with Cigna member services (1-800-244-6224) or Express Scripts before starting treatment.
Florida’s Mental Health and Substance Use Disorder Parity Law (Fla. Stat. § 627.6574 and § 627.6578) requires that fully-insured health plans cover mental health and substance use disorder services at parity with medical and surgical benefits. While these statutes primarily address mental health parity, they interact with weight loss coverage through the following mechanisms:
ERISA carve-out: Self-funded employer plans are governed by federal ERISA law and are exempt from Florida state insurance mandates, including the parity statutes above. If you are on a self-funded employer plan (common at large companies), Florida parity law may not apply. The federal MHPAEA still applies to most self-funded group health plans.
Under the Affordable Care Act (ACA) Section 2713, non-grandfathered Cigna health plans in Florida must cover certain preventive services at no cost-sharing. For weight management, this may include:
This preventive benefit applies to the counseling service itself — it does not mandate coverage of GLP-1 medications. Drug coverage for weight management remains a separate pharmacy benefit subject to formulary and PA requirements. Verify your specific preventive benefits with Cigna.
If you are enrolled in a Cigna HDHP paired with an HSA in Florida:
Consult your plan’s Summary of Benefits or a benefits advisor to confirm HDHP-specific rules for weight loss medication coverage.
Florida Medicaid (managed through Sunshine Health, Molina, and other managed care organizations) has limited coverage for GLP-1 weight loss medications. Florida Medicaid generally does not cover GLP-1 medications for obesity as a primary indication. Medicaid coverage for weight management is primarily limited to behavioral counseling services. If you are a Florida Medicaid beneficiary considering weight loss treatment, contact your managed care organization to verify what obesity management benefits may be available to you.
If your Cigna plan does not cover your prescribed weight loss medication, or if prior authorization is denied, manufacturer patient assistance programs may offer significant cost savings:
PAP eligibility and program terms are subject to change. Contact the manufacturer directly to confirm current program availability and income requirements.
Check if your Cigna plan may cover weight loss treatment at Klarity Health in Florida.
Cigna plans in Florida may cover weight loss treatment, including medical obesity management and prescription medications, depending on your specific plan type, employer design, and Express Scripts formulary. Coverage for GLP-1 medications is subject to prior authorization and medical necessity documentation. Verify your specific benefits with Cigna (1-800-244-6224) or through Klarity’s benefits check before booking.
Many Cigna commercial plans in Florida may cover Wegovy (semaglutide 2.4 mg) through Express Scripts at Tier 3–4, subject to prior authorization. PA criteria typically include BMI ≥ 30 or ≥ 27 with a weight-related comorbidity, documentation of medical necessity, and often prior participation in a structured lifestyle program. Coverage is not guaranteed and depends on your specific employer plan design. Verify your current formulary at express-scripts.com or through your myCigna portal.
Zepbound (tirzepatide for weight management) coverage under Cigna/Express Scripts plans in Florida varies by plan design. Express Scripts’ formulary positioning for Zepbound differs from CVS/Caremark (which removed Zepbound from most plans effective July 2025). Some Cigna employer plans may cover Zepbound with prior authorization, while others may not include it. Check your current plan’s Express Scripts formulary or contact Cigna member services for confirmation. If denied, the LillyAssist PAP (1-800-545-5979) may provide cost assistance.
Yes — most Cigna plans in Florida require prior authorization for GLP-1 weight loss medications (Wegovy, Zepbound, Saxenda) through Express Scripts. PA criteria typically include BMI documentation, evidence of comorbidities, and prior lifestyle program participation. Klarity Health’s clinical team may assist with prior authorization submission. PA approval timelines vary by plan.
Copays for weight loss visits and GLP-1 medications with Cigna in Florida vary by plan type, formulary tier, deductible status, and whether PA has been approved. GLP-1 medications at Tier 3–4 typically carry higher cost-sharing than generic medications. On HDHP plans, you pay full cost until your deductible is met. Review your plan’s Summary of Benefits or call Cigna member services (1-800-244-6224) for your specific cost estimate before starting care.
Many Cigna plans in Florida include telehealth benefits for weight management consultations. Telehealth coverage for GLP-1 medication management is subject to the same medical necessity and PA requirements as in-person care. Verify your telehealth weight loss benefits with Cigna or use Klarity’s benefits check before booking an online consultation.
HSA funds may be used to pay for eligible medical expenses, which can include prescription weight loss medications and qualifying obesity management consultations. GLP-1 medications (Wegovy, Zepbound) are prescription drugs, and HSA-eligible use is generally permitted when prescribed for a qualifying medical condition such as obesity. Consult a tax advisor for HSA eligibility specifics and review your HDHP plan design for deductible rules.
If Cigna denies PA for a GLP-1 or other weight loss medication, you have several options: (1) Request a peer-to-peer review between your Klarity provider and the Cigna medical reviewer; (2) File a formal appeal with clinical documentation — Cigna plans are required to respond within standard timeframes; (3) Invoke Florida’s step therapy override rights under Fla. Stat. § 627.42397 if the denial is based on step therapy requirements; (4) Apply for manufacturer PAPs (NovoCare, LillyAssist) for cost assistance if coverage is not available; (5) Contact the Florida Office of Insurance Regulation (FL OIR) at 1-877-693-5236 if you believe your fully-insured plan has violated Florida insurance law.
Disclaimer: Klarity Health is an independent telehealth platform and is not affiliated with Cigna, Evernorth Health Services, Express Scripts, or MDLIVE. Insurance coverage varies by plan, employer, and formulary design. The information on this page is intended as general educational guidance only and does not constitute a guarantee of benefits, formulary inclusion, or prior authorization approval. Formulary tiers and PA criteria are subject to change by Express Scripts. Coverage for GLP-1 medications varies significantly by plan — verify your specific benefits with Cigna or through Klarity’s benefits check before starting treatment. For complaints about a fully-insured Florida health plan, contact the Florida Office of Insurance Regulation at 1-877-693-5236.
Find the right provider for your needs — select your state to find expert care near you.